Related Experiment Video
Updated: Oct 24, 2025

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Chronic venous insufficiency, cardiovascular disease, and mortality: a population study
Jürgen H Prochaska1,2,3, Natalie Arnold1, Andrea Falcke1
1Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, Mainz 55131, Germany.
Insights
Chronic venous insufficiency (CVI) is common and linked to cardiovascular issues. Individuals with CVI face a higher mortality risk, independent of other health factors, highlighting its significant health burden.
Area of Science:
- Vascular Medicine
- Epidemiology
- Public Health
Background:
- Chronic venous insufficiency (CVI) significantly impacts population health, yet comprehensive data on its determinants and outcomes remain limited.
- Understanding the prevalence and clinical profile of CVI is crucial for public health initiatives and patient management.
Purpose of the Study:
- To determine the prevalence, clinical determinants, and prognostic impact of chronic venous insufficiency (CVI).
- To assess the association between CVI and cardiovascular comorbidities and overall mortality risk.
Main Methods:
- Systematic phenotyping of 12,423 participants using the CEAP classification within the Gutenberg Health Study.
- Multivariable Poisson regression and survival analyses were employed to evaluate CVI's association with cardiovascular disease and mortality.
- Findings were validated in the independent MyoVasc cohort.
Main Results:
- The prevalence of CVI was 40.8%. Key determinants included age, female sex, hypertension, obesity, smoking, and cardiovascular disease.
- Higher CVI severity (CEAP classes) correlated with an increased 10-year risk of incident cardiovascular disease.
- CVI independently predicted all-cause mortality (HR 1.46), a finding confirmed in the validation cohort.
Conclusions:
- Chronic venous insufficiency (CVI) is highly prevalent and significantly associated with cardiovascular risk factors and comorbidities.
- Individuals with CVI exhibit an elevated risk of all-cause mortality, independent of age, sex, and other clinical factors.
- These findings underscore the substantial health burden of CVI and its implications for long-term patient outcomes.
Aims:
Evidence regarding the health burden of chronic venous insufficiency (CVI), its clinical determinants, and impact on outcome is scarce.
Methods And Results:
Systematic phenotyping of CVI according to established CEAP (Clinical-Etiologic-Anatomic-Pathophysiologic) classification was performed in 12 423 participants (age range: 40-80 years) of the Gutenberg Health Study from April 2012 to April 2017. Prevalence was calculated age- and sex-specifically. Multivariable Poisson regression models were calculated to evaluate the relation of CVI with cardiovascular comorbidities. Survival analyses were carried out to assess the CVI-associated risk of death. Replication of findings was done in an independent cohort study (MyoVasc, NCT04064450). The prevalence of telangiectasia/reticular, varicose veins, and CVI was 36.5% [95% confidence interval (CI), 35.6-37.4%], 13.3% [12.6-13.9%], and 40.8% [39.9-41.7%], respectively. Age, female sex, arterial hypertension, obesity, smoking, and clinically overt cardiovascular disease were identified as clinical determinants of CVI. Higher CEAP classes were associated with a higher predicted 10-year risk for incident cardiovascular disease in individuals free of cardiovascular disease (n = 9923). During a mean follow-up of 6.4 ± 1.6 years, CVI was a strong predictor of all-cause death independent of the concomitant clinical profile and medication [hazard ratio (HR) 1.46 (95% CI 1.19-1.79), P = 0. 0003]. The association of CVI with an increased risk of all-cause death was externally validated in the MyoVasc cohort [HR 1.51 (95% CI 1.11-2.05), P = 0.009].
Conclusion:
Chronic venous insufficiency is highly prevalent in the population and is associated with the presence of cardiovascular risk factors and disease. Individuals with CVI experience an elevated risk of death, which is independent of age and sex, and present cardiovascular risk factors and comorbidities.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction

